2003
DOI: 10.1016/s0967-2109(02)00113-8
|View full text |Cite
|
Sign up to set email alerts
|

The chemically treated bovine ureter—clinical performance of a novel biological vascular prosthesis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
5
0
1

Year Published

2004
2004
2021
2021

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 17 publications
(7 citation statements)
references
References 15 publications
0
5
0
1
Order By: Relevance
“…Although autogenous vein has satisfactory long-term patency, some patients who need bypass surgery do not have suitable autologous vein; diameter mismatch between the autogenous vein and host vessel remains problematic, and spiral vein grafts are rarely used since they are technically demanding. 7 Accordingly, several biological vascular grafts have been developed for clinical use, including cryopreserved allografts 8 , human umbilical vein grafts 9 , and xenografts 10 , 11 . Xenogeneic tissue can be used as a bioengineered vascular scaffold 12 , 13 , and several commonly used xenogeneic decellularized patches derived from porcine or bovine pericardium are commercially available.…”
Section: Introductionmentioning
confidence: 99%
“…Although autogenous vein has satisfactory long-term patency, some patients who need bypass surgery do not have suitable autologous vein; diameter mismatch between the autogenous vein and host vessel remains problematic, and spiral vein grafts are rarely used since they are technically demanding. 7 Accordingly, several biological vascular grafts have been developed for clinical use, including cryopreserved allografts 8 , human umbilical vein grafts 9 , and xenografts 10 , 11 . Xenogeneic tissue can be used as a bioengineered vascular scaffold 12 , 13 , and several commonly used xenogeneic decellularized patches derived from porcine or bovine pericardium are commercially available.…”
Section: Introductionmentioning
confidence: 99%
“…These chemically treated bioprostheses do not undergo tissue ingrowth and intimal hyperplasia as PTFE grafts do [11]. This was thought to be due to the low porosity of their wall structure.…”
Section: Discussionmentioning
confidence: 99%
“…E. Allaire et al [30] réticulent chimiquement une matrice aortique décellularisée et l'ensemencent avec des cellules musculaires lisses vasculaires. La matrice de collagène fibrillaire peut être obtenue à partir d'uretère bovin réticulé chimiquement [31], de fascia musculaire dorsal chez le lapin [32] ou de sous-muqueuse intestinale implantée en position artérielle [33]. Ces sources tissulaires semblent donc présenter un intérêt comme substitut vasculaire.…”
Section: Reconstitution De Vaisseaux Par Génie Tissulaireunclassified